Atlas Trials

Inducing Remission in Type 1 Diabetes With Alefacept

Clinical trial NCT00965458 · TERMINATED

Trial details

NCT number
NCT00965458
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
New-onset Type 1 Diabetes Mellitus
Start date
2011-03-01
Primary completion
2013-03-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.